SCHEMBL714295

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL712028	0.98	PABPC1 (0.36)	PABPC1CTDSP1GAAAPLNRHTR1A
	SCHEMBL711781	0.95	APLNR (0.32)	PABPC1CTDSP1GAAAPLNR
	SCHEMBL7709855	0.84	GAA (0.35)	PABPC1CTDSP1GAAHTR1A
	SCHEMBL8207062	0.82	SLC6A2 (0.32)	APLNRHTR1A
	SCHEMBL712250	0.82	GAA (0.32)	GAAAPLNR
	SCHEMBL8382509	0.80	GAA (0.34)	PABPC1CTDSP1GAAHTR1ATMEM97
	SCHEMBL13381234	0.76	PABPC1 (0.37)	PABPC1CTDSP1GAAHTR1ATMEM97
	SCHEMBL2490143	0.76	—	—
	SCHEMBL2491845	0.76	—	—
	SCHEMBL2492248	0.76	—	—

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.